DCVC Bio
Overview
DCVC Bio is a venture capital firm that invests in early-stage deep tech startups in the life sciences. It is the life sciences-focused investment arm of the parent firm, DCVC (Data Collective). The firm's strategy is to invest in scientific breakthroughs and computation-enhanced platforms that can generate new arrays of treatments or products, rather than investing in specific drugs or molecules. Its focus areas include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies that unify data and leverage artificial intelligence and automation. DCVC Bio was co-founded in 2018 by DCVC founders Matt Ocko and Zachary Bogue, along with Dr. John Hamer and Dr. Kiersten Stead.
Portfolio Companies
38
Website
dcvc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Orca Bio | Jun 2020 | Series D | Co-investor |
| Umoja Biopharma | Jan 2025 | Series C | Lead |
| Unlearn | Feb 2024 | Series C | Co-investor |
| Auron Therapeutics | Feb 2025 | Series B | Lead |
| Solu Therapeutics | Apr 2025 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Zachary Bogue
Co-Founder and Co-Managing Partner
John Hamer
Managing Partner, DCVC Bio
Kiersten Stead
Managing Partner
Matt Ocko
Co-Managing Partner
Justin Kern
Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DCVC Bio based?
DCVC Bio is headquartered in San Francisco, California, United States.
When was DCVC Bio founded?
Founding year information for DCVC Bio is not publicly available.
How many portfolio companies does DCVC Bio have?
DCVC Bio has 38 portfolio companies in Caplight's dataset.
What are some companies in DCVC Bio's portfolio?
Portfolio companies visible on Caplight include Orca Bio, Umoja Biopharma, Unlearn, Auron Therapeutics, Solu Therapeutics.
What was DCVC Bio's most recent investment shown here?
DCVC Bio's most recent investment in this portfolio sample was in Solu Therapeutics in 2025.
What sectors does DCVC Bio focus on?
DCVC Bio focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Energy & Sustainability, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does DCVC Bio focus on?
DCVC Bio typically invests at the Early stage.